Xian Li

Title: Innovations by Inventor Xian Li

Introduction

Xian Li is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating serious health conditions. With a total of 2 patents, his work reflects a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Xian Li's latest patents include a composition for preventing or treating cancer. This innovative pharmaceutical composition not only aims to inhibit tumor growth but also enhances immune functions and addresses cachexia caused by tumors. Furthermore, it has been shown to have a synergistic effect when co-administered with existing anticancer drugs. Another significant patent focuses on methods for treating inflammatory diseases. This composition, which includes active ingredients such as Mel, is designed for antitussive, expectorant, or anti-inflammatory actions. It has demonstrated excellent effects compared to existing agents and is derived from natural materials, ensuring low cytotoxicity and safe usage as a medicine or food composition.

Career Highlights

Xian Li is currently associated with Okchundang Co., Ltd., where he continues to innovate and contribute to the field of pharmaceutical sciences. His work is characterized by a strong focus on developing effective treatments for critical health issues.

Collaborations

Xian Li collaborates with talented coworkers, including Sae Kwang Ku and Seong Min Ku. Their combined expertise enhances the research and development efforts at Okchundang Co., Ltd.

Conclusion

Xian Li's contributions to pharmaceutical innovations are noteworthy, particularly in the areas of cancer treatment and inflammatory disease management. His patents reflect a dedication to improving health outcomes through scientific advancements.